We invest in a healthier future

Sarsia's highly experienced team of engineers, technologists, biologists and pharmacologists identify and support, through active ownership, innovative research-based companies working to develop and bring to market products with a high medical need.

Life Science prospects are "born global". With world-class research, investing in the European Life Science sector is an attractive proposition. Sarsia is Norway’s leading early-stage Life Science investment firm investing in Europe with a special focus on the Nordics. We combine our technological knowledge and solid understanding of the market, with a vibrant international network.